S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CDXC ChromaDex Corporation

3.78

0.00 (0.00%)

Pre Market

Last Updated: 06:59:20

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more ChromaDex Charts.

ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more ChromaDex Charts.

Chromadex Corp. News

ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement
Tuesday 30 April 2024 (6 days ago) • Business Wire

ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®
Thursday 25 April 2024 (2 weeks ago) • Business Wire

ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Wednesday 24 April 2024 (2 weeks ago) • Business Wire

ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market
Tuesday 23 April 2024 (2 weeks ago) • Business Wire

ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program
Tuesday 26 March 2024 (1 month ago) • Business Wire

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results
Wednesday 6 March 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)

ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024
Wednesday 21 February 2024 (2 months ago) • Business Wire

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Monday, February 12, 2024
Monday 5 February 2024 (3 months ago) • Business Wire

More Chromadex Corp. News Articles

TheGlobe com (PK)

Kraig Biocraft Laborator... (QB)

Digital Brand Media and ... (PK)

Voip Pal Com (QB)

Bell Buckle (PK)

Impact Fusion (PK)

Northwest Biotherapeutics (QB)

Lightwave Logic

Enzolytics (PK)

Fannie Mae (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions